AbbVie (ABBV) Gross Profit (2012 - 2026)
AbbVie (ABBV) posted quarterly Gross Profit of $10.8 billion for Q1 2026, up 15.45% year-over-year from $9.3 billion in Q1 2025, and down 10.62% quarter-over-quarter from $12.1 billion in Q4 2025.
AbbVie (ABBV) Gross Profit (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Gross Profit for 15 consecutive years, with $10.8 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Profit rose 15.45% year-over-year to $10.8 billion; the TTM figure through Mar 2026 stood at $44.4 billion (up 9.48% YoY), while the FY2025 annual figure was $43.0 billion, up 8.94% from the prior year.
- Gross Profit fell to $10.8 billion in Q1 2026 per ABBV's latest filing, from $12.1 billion in the prior quarter.
- Across five years, Gross Profit topped out at $12.1 billion in Q4 2025 and bottomed at $7.4 billion in Q3 2023.
- Historically, Gross Profit has averaged $9.9 billion across 5 years, with a median of $10.2 billion in 2024.
- Annual changes were most pronounced in 2023 — Gross Profit dropped 23.98% — and 2024, when it soared 37.7%.
- AbbVie's Gross Profit stood at $11.0 billion in 2022, then fell by 21.5% to $8.6 billion in 2023, then increased by 24.53% to $10.7 billion in 2024, then advanced by 12.7% to $12.1 billion in 2025, then declined by 10.62% to $10.8 billion in 2026.
- Business Quant data shows ABBV's Gross Profit at $10.8 billion in Q1 2026, $12.1 billion in Q4 2025, and $10.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.70 Bn |
| Jun 30, 2026 | 12.70 Bn |
| Mar 31, 2026 | 10.78 Bn |
| Mar 31, 2026 | 10.78 Bn |
| Dec 31, 2025 | 12.07 Bn |
| Dec 31, 2025 | 12.07 Bn |
| Sep 30, 2025 | 10.47 Bn |
| Sep 30, 2025 | 10.47 Bn |
| Jun 30, 2025 | 11.08 Bn |
| Jun 30, 2025 | 11.08 Bn |
| Mar 31, 2025 | 9.34 Bn |
| Mar 31, 2025 | 9.34 Bn |
| Dec 31, 2024 | 10.71 Bn |
| Dec 31, 2024 | 10.71 Bn |
| Sep 30, 2024 | 10.25 Bn |
| Sep 30, 2024 | 10.25 Bn |
| Jun 30, 2024 | 10.26 Bn |
| Jun 30, 2024 | 10.26 Bn |
| Mar 31, 2024 | 8.22 Bn |
| Mar 31, 2024 | 8.22 Bn |